Spontaneous Peripartum Cardiomyopathy Relapse
Asian Journal of Case Reports in Medicine and Health,
Peripartum cardiomyopathy (PPCM) is heart failure occurring without any determinable heart disease during the last month of pregnancy or the first six months postpartum. PPCM may be underappreciated, as many patients stop follow-up as soon as they achieve a normal EF. We contribute with an unusual case of short-lived cardiomyopathy in a 36-year-old female, while in this hospitalization was experiencing stressful circumstances, in the absence of pregnancy and other apparent causes of cardiomyopathy, yet to recover two days later. We believe with a history of PPCM in a prior pregnancy; this could be a PPCM relapse after excluding viral and connective tissue etiology. It is unclear when a patient with PPCM may be considered fully recovered and heart failure medications safely discontinued. Restoration of ejection fraction (EF) may not represent complete recovery. The lessons learned here are that there are no PPCM guidelines, limited conflicting data exist regarding the long-term management of PPCM patients with recovered LV function, and relapse of PPCM may be misdiagnosed with Takotsubo syndrome.
- Peripartum cardiomyopathy
- PPCM relapse
How to Cite
Chinweuba GC, Rutkofsky IH. Unveiling the Mystery of Peripartum Cardiomyopathy: A Traditional Review. Cureus. 2020;12(10):e10790.
Published 2020 Oct 4.
Iorgoveanu C, Zaghloul A, Ashwath M. Peripartum cardiomyopathy: A review. Heart Fail Rev. 2021;26(6):1287- 1296.
Bauersachs J, König T, van der Meer P, et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019;21(7):827-843.
Honigberg MC, Givertz MM. Peripartum cardiomyopathy. BMJ. 2019;364:k5287.
Published 2019 Jan 30.
Yamac H, Bultmann I, Sliwa K, Hilfiker-Kleiner D. Prolactin: A new therapeutic target in peripartum cardiomyopathy. Heart. 2010;96(17):1352-1357.
Chen MM, Coakley FV, Kaimal A, Laros RK Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol. 2008;112(2 Pt 1):333-340.
Leurent G, Baruteau AE, Larralde A, et al. Contribution of cardiac MRI in the comprehension of peripartum cardiomyopathy pathogenesis. Int J Cardiol. 2009;132(3):e91-e93.
Fett JD, Fristoe KL, Welsh SN. Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers. Int J Gynaecol Obstet. 2010;109(1):34-36.
Asch FM, Medvedofsky D. Functional mitral regurgitation. Curr Opin Cardiol. 2020;35(5):464-473.
Mahowald MK, Davis M. Case Series: Spontaneous Relapse after Recovery From Peripartum Cardiomyopathy. Clin Med Insights Case Rep. 2017;10: 1179547617749227.
Published 2017 Dec 17.
Aldridge S, Gracia E, Harrington CM, Meyer TE, Kovell LC. Recurrent and Life-Threatening Peripartum Cardiomyopathy: Diagnosis, Delivery Considerations, and Management. JACC Case Rep. 2020; 2(4):681-684.
Published 2020 Apr 15.
Greulich S, Deluigi CC, Gloeckler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6(4):501-511.
Grün S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol. 2012;59(18):1604-1615.
DOI: 10.1016/j.jacc.2012.01.007 14
Scardovi AB, De Maria R. La cardiomiopatia peripartum: una malattia poco nota [Peripartum cardiomyopathy: a little known disease]. G Ital Cardiol (Rome). 2018;19(4):209-221.
Karaye KM, Henein MY. Peripartum cardiomyopathy: a review article. Int J Cardiol. 2013;164(1):33-38.
Halliday BP, Wassall R, Lota AS, et al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet. 2019;393(10166):61-73.
Abstract View: 52 times
PDF Download: 10 times